{{scheme.chgp}}%
{{scheme.chgp}}%
No Matches Found
{{scheme.chgp}}%
No Matches Found
No Matches Found
Neuland Laboratories Ltd
Neuland Labs. Sees Revision in Market Assessment Amid Strong Financial Trends
Neuland Labs., a small-cap player in the Pharmaceuticals & Biotechnology sector, has experienced a revision in its market evaluation, reflecting shifts in its financial and technical outlook. This adjustment follows notable developments in the company’s operational performance and market positioning.
Why is Neuland Labs. falling/rising?
As of 20-Nov, Neuland Laboratories Ltd's stock price is at 16,850.00, down 1.27% and underperforming with a 3.47% loss over the last four days. Despite trading above longer-term moving averages, reduced investor interest and poor long-term growth prospects contribute to the stock's decline.
Neuland Laboratories Hits New 52-Week High of Rs. 19,748.4
Neuland Laboratories has achieved a new 52-week high, reflecting strong performance in the pharmaceutical sector. The company has shown consistent upward momentum, with significant gains over recent days. It has delivered impressive financial results and maintains high institutional holdings, indicating a solid market position.
Neuland Laboratories Hits New 52-Week High of Rs. 19,748.4
Neuland Laboratories has achieved a new 52-week high, reflecting strong performance in the pharmaceutical sector. The company has shown consistent upward momentum, with significant gains over recent days. It reported impressive financial metrics, including record operating cash flow and net sales, highlighting its growth potential and stability.
Neuland Laboratories Ltd Surges 6.52% with Rs 39.07 Lakhs in Trade Value Today
Neuland Laboratories Ltd has become one of the most active stocks in the Pharmaceuticals & Biotechnology sector, with a trading volume of 204,411 shares and a market capitalization of Rs 22,786 crore. The stock has shown strong performance, reaching a new 52-week high and trading above key moving averages.
Neuland Laboratories Soars to All-Time High, Signaling Unmatched Market Confidence
Neuland Laboratories has reached an all-time high, showcasing its strong position in the Pharmaceuticals & Biotechnology sector. The stock has demonstrated impressive momentum, with significant gains over recent days and a high level of intraday volatility. The company also boasts strong financial metrics and high institutional holdings.
How has been the historical performance of Neuland Labs.?
Neuland Labs experienced fluctuating financial performance, with net sales and operating income peaking at 1,558.58 Cr in March 2024 before declining to 1,476.84 Cr in March 2025, while profit metrics also decreased. However, total assets and cash flow from operating activities improved during the same period.
Why is Neuland Labs. falling/rising?
As of 04-Nov, Neuland Laboratories Ltd is currently priced at Rs 17,632.90, reflecting a 2.81% increase and strong performance with a 28.01% year-to-date rise. The stock has outperformed the broader market significantly, indicating robust investor confidence and positive trading trends.
Why is Neuland Labs. falling/rising?
As of 31-Oct, Neuland Laboratories Ltd is experiencing a price increase to Rs 16,560.00, reflecting a 2.42% rise. The stock has shown strong performance, outperforming its sector and the Sensex, with consistent returns and positive investor sentiment due to low debt and high institutional holdings.
Why is Neuland Labs. falling/rising?
As of 29-Oct, Neuland Laboratories Ltd's stock price is Rs 15,374.40, down 2.33% after six consecutive days of decline. Despite a strong long-term performance and solid debt servicing capability, recent underperformance against the market indicates specific challenges.
Why is Neuland Labs. falling/rising?
As of 10-Oct, Neuland Laboratories Ltd's stock price is Rs 16,276.55, up 3.58%, with a strong performance over recent days and impressive returns over the past year and three years. Despite a decline in investor participation, the stock remains attractive due to its strong fundamentals and outperformance compared to the benchmark Sensex.
Is Neuland Labs. technically bullish or bearish?
As of October 8, 2025, the trend has shifted to bullish with strong indicators like the weekly MACD and Bollinger Bands supporting this view, although caution is advised due to mildly bearish monthly MACD and KST signals.
Neuland Laboratories Adjusts Outlook Amid Mixed Technical Indicators and Sales Decline
Neuland Laboratories has recently experienced a score adjustment reflecting a shift in technical trends. While technical indicators show mixed signals, the company has faced challenges with a notable decline in net sales. Despite this, it maintains a strong debt servicing capability and significant institutional backing.
Neuland Laboratories Shows Mixed Technical Trends Amid Strong Performance Gains
Neuland Laboratories, a small-cap pharmaceutical company, has experienced notable stock price fluctuations, currently trading at 15,458.85. Despite mixed technical indicators, the company has shown impressive performance, returning 31.90% over the past year and 945.58% over three years, significantly outperforming the Sensex.
How has been the historical performance of Neuland Labs.?
Neuland Labs experienced a generally upward trend in key financial metrics, peaking in March 2024, but saw declines in net sales, operating profit, and profits after tax in March 2025. Despite these declines, the company maintained a strong asset base and improved cash flow from operations.
Neuland Laboratories Shows Mixed Technical Trends Amidst Market Volatility
Neuland Laboratories, a small-cap pharmaceutical company, has experienced notable stock price movements recently, reflecting market volatility. The company has shown impressive returns over the past year, significantly outperforming the Sensex, with remarkable long-term gains over three and five years, indicating strong market resilience.
Is Neuland Labs. technically bullish or bearish?
As of October 1, 2025, Neuland Labs shows a mildly bullish trend, supported by bullish weekly moving averages and Bollinger Bands, despite mixed signals from the MACD and some selling pressure indicated by the OBV.
Why is Neuland Labs. falling/rising?
As of 01-Oct, Neuland Laboratories Ltd is experiencing a price increase to 15,400.00, reflecting a 5.32% rise. The stock has shown strong short-term performance, outperforming its sector and trading above key moving averages, although recent negative results may pose long-term risks.
Neuland Laboratories Shows Mixed Technical Trends Amid Strong Long-Term Performance
Neuland Laboratories, a small-cap pharmaceutical company, has recently revised its evaluation amid changing market conditions. The stock has shown strong annual performance, significantly outperforming the Sensex. Technical indicators present a mixed outlook, with short-term bullish trends contrasted by more cautious monthly metrics, highlighting the company's resilience in the market.
{{list.post_title}}
{{list.post_excerpt}}
{{list.post_title}}
{{list.post_excerpt}}
